Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over

Bowel cancer, also known as colorectal cancer, is very common in older people. More than half of all cases happen in those aged 70 and over. When someone has Stage III colon cancer, it means the cancer has spread to nearby lymph nodes but not to distant parts of the body. After surgery to remove the cancer, doctors often suggest extra treatment called chemotherapy. This 'adjuvant' chemotherapy aims to kill any remaining cancer cells and reduce the chance of the cancer coming back.

However, it's not always straightforward for older patients. Sometimes, the chemotherapy that works well for younger people can have noticeable side effects in older adults. Previous studies haven't included many very elderly patients, so doctors aren't sure if the standard treatments are always the best choice for this age group, or if a gentler approach, or even no chemotherapy, might be better for some. There's also a question about whether a stronger chemotherapy, which combines different drugs, offers real benefits for older patients compared to a single drug treatment.

This study is trying to answer these important questions. It will compare different chemotherapy options, and in some cases, no chemotherapy, to see what helps older patients live longer without their cancer returning. The study carefully divides patients based on their overall health and how well they can cope with treatment, after a thorough check-up, including one with a specialist in older people's health (a geriatrician). By doing this, the researchers hope to find clearer guidance on the most effective and safest treatments for older people with Stage III colon cancer.